|
|
|
 Dr. Murray Urowitz received his M.D. from the University of Toronto and completed his post-graduate training in rheumatology at the Johns Hopkins University, Baltimore and at the University of Toronto. He is currently Professor of Medicine at the University of Toronto and Director of the Centre for Prognosis Studies in the Rheumatic Diseases and the University of Toronto and the Lupus Clinic at the Toronto Western Hospital.Dr. Urowitz established the University of Toronto Lupus Clinic and Lupus Databank Research Program in 1970. This extensive longitudinal database is one of the largest such databanks in the world with over 1800 patients and has allowed for numerous findings which have changed the way lupus is diagnosed and managed. Dr. Urowitz has published over 300 peer-reviewed papers and 40 book chapters.Dr. Urowitz was a founding member of the Ontario Lupus Association (now Lupus Ontario). He was president of the Lupus Council of the American Rheumatology Association. He was a founding member of the Systemic Lupus International Collaborating Clinics (SLICC) group and currently directs the SLICC Registry for Atherosclerosis. In 1995 he was the recipient of the Distinguished Rheumatologist Award of the Canadian Rheumatology Association and in 2009 he was recipient of the Evelyn V. HESS Award for outstanding contributions to lupus research, awarded by the Lupus Foundation of America. In 2012 he was awarded a Queen Elizabeth Diamond Jubilee Medal nominated by the Canadian Rheumatology Association in recognition of his longstanding contributions to lupus research and his work in the field of rheumatology. |
|
 Dr. Daniel Wallace received his MD at the University of Southern California. He is Board Certified in both Internal Medicine and Rheumatology, and the author of 8 medical textbooks, 25 book chapters, and over 340 medical publications, the latter have appeared in the New England Journal of Medicine, Annals of Internal Medicine, the Lancet, Journal of Clinical Investigation, Journal of Immunology, and Journal of the American Medical Association.Dr. Wallace’s academic efforts include having served as Chief of Rheumatology at Cedars-Sinai Medical Center, Century City Hospital, and the City of Hope Medical Center in Duarte, CA. He is currently a Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA. His clinical practice is based at Cedars-Sinai, where he is involved in the care of 2,000 lupus patients, the largest practice of its kind in the United States and co- directs the Cedars Sinai Rheumatology fellowship program. The Wallace Rheumatic Disease Research Center currently runs over 30 clinical trials for patients with rheumatoid arthritis, lupus, ankylosing spondylitis, psoriatic arthritis and fibromyalgia.Dr. Wallace’s volunteer work has entailed serving as Chairman of the Lupus Foundation of America, the Research and Education Foundation of the American College of Rheumatology, and on the Board of Directors of the United Scleroderma Foundation, the Lupus Research Institute and the American Society for Apheresis. He has served on the Medical Advisory Board of the Sjogren’s Syndrome Foundation and the American Fibromyalgia Syndrome Association. Dr. Wallace is the recipient of the Lupus Foundation of America Humanitarian Award, Achievement award of the Lupus Research Institute, Spirit Award of the Scleroderma Foundation, the Jane Wyman Humanitarian Award of the Arthritis Foundation, and the Healthcare Professional Leadership Award from the Sjogren’s Syndrome Foundation. |
 Prof. David Isenberg was trained at St Bartholomew’s Hospital in London, and did his clinical training in North London hospitals and his basic research training in laboratories directed by Ivan Roitt (The Middlesex Hospital London) and Robert Schwartz (New England Medical Centre in Boston). Prof. Isenberg is the academic director of Rheumatology at University College London. Prof. Isenberg has ‘been associated’ with the SLE cohort at University College Hospital, London (650 patients) since 1979; chair the BILAG group (responsible for developing the BILAG index) and was previously chair of SLICC and ex-president of the British Society for Rheumatology (2004-2006), and ex-Chair of the BSR’s Biologics Register Committee (2006-2011). Currently chairing Lupus UK’s Research Committee and a Local Clinical Trials Network Enabling Group in North London. Prof. Isenberg won the Hess prize (2010) awarded by the Lupus Foundation of America for outstanding contribution to SLE Research – the first non-North American to win it. |
| Dr. Lee Simon has been a Rheumatologist for 36 years. He has extensive experience in drug development in the US, and has served on consulting advisory boards for many companies and federal associations including more than seven years as a voting member of various advisory committees tor the U.S. FDA, eventually serving as a Division Director of Analgesic, Anti- inflammatory and Ophthalmologic Drug Products for several years. He has been awarded the 2003 Distinguished Service Award of the ACR and the 2003 Scientific Leadership Award of the Lupus Research Institute. He has served on the Steering Committee of IMPAACT, a group developing recommendations for the design and implementation of clinical trials investigating pain and serves on the executive committees of both OMERACT, a group developing outcome measures for rheumatic disease clinical trials and ACTTION, a public/private partnership with the FDA to develop improved clinical trials studying pain outcome. Dr. Simon has also been on the editorial board of multiple journals, has authored more than 110 original publications, review articles and chapters, and has served as a co-editor of four books. |
|
|
|
|
